Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:918-925

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.-T.
Right arrow Articles by Karliner, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.-T.
Right arrow Articles by Karliner, J. S.

(Circulation. 1995;92:918-925.)
© 1995 American Heart Association, Inc.


Articles

Chronic Hypoxia Differentially Regulates {alpha}1-Adrenergic Receptor Subtype mRNAs and Inhibits {alpha}1-Adrenergic Receptor–Stimulated Cardiac Hypertrophy and Signaling

Hong-Tai Li, MD; Carlin S. Long, MD; D. Gregg Rokosh, PhD; Norman Y. Honbo, MA; Joel S. Karliner, MD

From the Cardiology Section, Veterans Affairs Medical Center, the Cardiovascular Research Institute and the Department of Medicine, University of California, San Francisco.

Correspondence to Joel S. Karliner, MD, Cardiology Section (111C), Veterans Affairs Medical Center, 4150 Clement St, San Francisco, CA 94121.

Background After myocardial ischemia and/or infarction, surviving cardiac myocytes in and around the injured zone develop hypertrophy to compensate for the loss of contractile units due to myocyte injury and death. One of the factors that may be involved in the development of hypertrophy after ischemic injury is norepinephrine (NE), an agent that induces hypertrophy of cardiac myocytes through the {alpha}1-adrenergic receptor (AR). It is not known, however, whether hypoxia, a major component of ischemia, has any direct effect on NE-stimulated hypertrophy. Therefore, we sought to determine whether chronic hypoxia could alter NE-stimulated hypertrophy and if so, whether this alteration was related to {alpha}1-AR–mediated signaling and {alpha}1-AR changes at both the protein and mRNA levels.

Methods and Results We developed a model of chronic hypoxia in cultured neonatal rat cardiac myocytes in which myocytes were exposed to 1% oxygen for 72 hours. Initially, we observed that chronic hypoxia inhibited NE-stimulated hypertrophy, as reflected by decreases in both new protein synthesis and total protein content during chronic hypoxia. Then we found that chronic hypoxia also inhibited {alpha}1-AR–transduced phosphatidylinositol hydrolysis, as indicated by a reduction in {alpha}1-AR–stimulated inositol phosphate production in hypoxic cells. These observations suggested that the inhibition of NE-stimulated hypertrophy seen during chronic hypoxia was due to impairment of {alpha}1-AR–mediated signaling and could result from changes in {alpha}1-AR numbers and/or subtype distribution. To address this issue, we determined {alpha}1-AR density and subtype distribution by radioligand binding and {alpha}1-AR subtype mRNAs, including {alpha}1A/D-, {alpha}1B-, and {alpha}1C-ARs, by RNase protection assays. We found that chronic hypoxia differentially regulated both the pharmacologically defined {alpha}1-AR subtypes and the mRNAs for the {alpha}1-AR subtypes. Thus, hypoxia for 72 hours coordinately downregulated both the pharmacologically defined {alpha}1A-AR density and the {alpha}1C-AR mRNA level. During normoxia, NE increased the pharmacologically defined {alpha}1A-AR density and the {alpha}1C-AR mRNA level, but hypoxia for 72 hours prevented these NE-mediated changes.

Conclusions Chronic hypoxia (1) inhibits {alpha}1-AR–mediated hypertrophy of cardiac myocytes and {alpha}1-AR–transduced phosphatidylinositol hydrolysis and (2) downregulates both the pharmacologically defined {alpha}1A-AR density and the {alpha}1C-AR mRNA level.


Key Words: receptors, adrenergic, alpha • hypoxia • hypertrophy • myocytes




This article has been cited by other articles:


Home page
CirculationHome page
C. B. Overgaard and V. Dzavik
Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease
Circulation, September 2, 2008; 118(10): 1047 - 1056.
[Full Text] [PDF]


Home page
FASEB J.Home page
G. A. Michelotti, D. M. Brinkley, D. P. Morris, M. P. Smith, R. J. Louie, and D. A. Schwinn
Epigenetic regulation of human {alpha}1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation
FASEB J, July 1, 2007; 21(9): 1979 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Mlynarczyk, T. Imamura, H. Umezaki, K.M. Kaushal, L. Zhang, and C.A. Ducsay
Long-Term Hypoxia Changes Myometrial Responsiveness and Oxytocin Receptors in the Pregnant Ewe: Differential Effects on Longitudinal Versus Circular Smooth Muscle
Biol Reprod, November 1, 2003; 69(5): 1500 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Leon-Velarde, M.-C. Bourin, R. Germack, K. Mohammadi, B. Crozatier, and J.-P. Richalet
Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R274 - R281.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Goetzl, H. Lee, T. Azuma, T. P. Stossel, C. W. Turck, and J. S. Karliner
Gelsolin Binding and Cellular Presentation of Lysophosphatidic Acid
J. Biol. Chem., May 5, 2000; 275(19): 14573 - 14578.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kacimi, J. Chentoufi, N. Honbo, C. S. Long, and J. S. Karliner
Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: Role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection
Cardiovasc Res, April 1, 2000; 46(1): 139 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kobayashi and D. E. Millhorn
Stimulation of Expression for the Adenosine A2A Receptor Gene by Hypoxia in PC12 Cells. A POTENTIAL ROLE IN CELL PROTECTION
J. Biol. Chem., July 16, 1999; 274(29): 20358 - 20365.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Kacimi, J. S. Karliner, F. Koudssi, and C. S. Long
Expression and Regulation of Adhesion Molecules in Cardiac Cells by Cytokines : Response to Acute Hypoxia
Circ. Res., March 23, 1998; 82(5): 576 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. R. M. Stassen, R. G. H. T. Maas, P. M. H. Schiffers, G. M. J. Janssen, and J. G. R. De Mey
A Positive and Reversible Relationship Between Adrenergic Nerves and Alpha-1A Adrenoceptors in Rat Arteries
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 399 - 405.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H.-T. Li, C. S. Long, M. O. Gray, D. G. Rokosh, N. Y. Honbo, and J. S. Karliner
Cross Talk Between Angiotensin AT1 and {alpha}1-Adrenergic Receptors : Angiotensin II Downregulates {alpha}1a-Adrenergic Receptor Subtype mRNA and Density in Neonatal Rat Cardiac Myocytes
Circ. Res., September 19, 1997; 81(3): 396 - 403.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Kacimi, C. S. Long, and J. S. Karliner
Chronic Hypoxia Modulates the Interleukin-1ß–Stimulated Inducible Nitric Oxide Synthase Pathway in Cardiac Myocytes
Circulation, September 16, 1997; 96(6): 1937 - 1943.
[Abstract] [Full Text]


Home page
CirculationHome page
H.-T. Li, N. Y. Honbo, and J. S. Karliner
Chronic Hypoxia Increases ß1-Adrenergic Receptor mRNA and Density but Not Signaling in Neonatal Rat Cardiac Myocytes
Circulation, December 15, 1996; 94(12): 3303 - 3310.
[Abstract] [Full Text]